ArticleCancer chemotherapy and pharmacology2020

C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma.

Go Noguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.